Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic epidural spinal cord compression.

John S Cole1, Roy A Patchell

  • 1Department of Neurosurgery, University of Kentucky Medical Center, Lexington, KY 40536, USA.

The Lancet. Neurology
|April 19, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A technique for approximating transition rates from published survival analyses.

Cost effectiveness and resource allocation : C/E·2019
Same author

Commentary (Kwok/Patchell): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma.

Oncology (Williston Park, N.Y.)·2017
Same author

Paramedic specialization: a strategy for better out-of-hospital care.

Air medical journal·2014
Same author

A 48-year-old man with severe shortness of breath.

Air medical journal·2014
Same author

ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases.

Journal of palliative medicine·2014
Same author

ACR Appropriateness Criteria® follow-up and retreatment of brain metastases.

American journal of clinical oncology·2012
Same journal

Resolution of expression of concern-Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

The Lancet. Neurology·2026
Same journal

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2026; 25: 631.

The Lancet. Neurology·2026
Same journal

Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2025; 24: 740-52.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2026; 25: 357-67.

The Lancet. Neurology·2026
See all related articles

Metastatic epidural spinal cord compression (MESCC) is a serious cancer complication causing back pain and potential paralysis. Rapid MRI diagnosis and treatments like corticosteroids, radiation, and surgery are crucial for preventing permanent damage.

Area of Science:

  • Oncology
  • Neurology
  • Radiology

Background:

  • Metastatic epidural spinal cord compression (MESCC) is a frequent complication in cancer patients, affecting approximately 5% of them.
  • The primary symptom of MESCC is back pain, signaling a critical medical emergency.
  • Delayed diagnosis and treatment of MESCC can lead to irreversible paralysis.

Purpose of the Study:

  • To summarize the current understanding of MESCC, including its incidence, symptoms, diagnosis, and treatment.
  • To highlight the urgency of diagnosing and treating MESCC to prevent neurological deficits.
  • To outline future research directions in MESCC management.

Main Methods:

  • Literature review of existing studies on MESCC.
  • Analysis of diagnostic modalities, focusing on Magnetic Resonance Imaging (MRI).

Related Experiment Videos

  • Overview of established therapeutic interventions, including corticosteroids, radiation therapy, and surgery.
  • Main Results:

    • MESCC is a common oncologic emergency with back pain as the most prevalent symptom.
    • MRI is the gold standard for diagnosing MESCC.
    • Established treatments include corticosteroids, radiation therapy, and surgical intervention.

    Conclusions:

    • MESCC requires prompt diagnosis and treatment to avert permanent paralysis.
    • Future research should prioritize prevention strategies, enhanced detection methods, and novel therapeutic approaches for MESCC.